Skip to main content
. 2010 Dec 29:26–455. doi: 10.1016/B978-0-443-07151-5.50005-6

Table 3.131.

Known risks to fetus of some drugs used systemically in dentistry

Categorya B C D and X
Either safe to fetus in animal models without human data, or risk in animal models but safe in human studies Risk to fetus in animal models but no human studies available, or no human studies support safety Definitive human data demonstrating risk to fetus

Use in dentistry Where necessary Only if really essential and after consulting physician Do not use

Local anaesthetics Lidocaine
Articaineb

Prilocainec Bupivacaine

Mepivacaine

Sedative agents Promethazine Benzodiazepines
Nitrous oxided

Analgesics Meperidine
Codeine
Aspirin
Paracetamol/acetaminophen Diflunisal NSAIDse

Antimicrobials Azithromycin
Aciclovir
Doxycycline
Cefadroxil
Ciprofloxacin
Minocycline
Cefuroxime
Clarithromycin
Tetracyclines
Cephalexin Fluconazole Co-trimoxazolef
Clindamycin

Antimicrobials Erythromycin


Loracarbef


Metronidazole


Penciclovir (cream)
Penicillins

Others Corticosteroids (even topical)
Antidepressants
Carbamazepine
Colchicine
Danazol
Phenytoin
Povidone-iodine applications
Retinoids
Thalidomide
Warfarin
a

US Federal Drug Agency (FDA) pregnancy categories; category A has not been included as this represents drugs with no risk to the fetus.

b

Sometimes categorised as B.

c

Prilocaine, at least in theory, can cause methaemoglobinaemia.

d

Nitrous oxide, though able to interfere with vitamin B12 and folate metabolism, does not appear to be teratogenic in normal use though it is advisable to restrict use to the second or third trimester.

e

May be safer in first and second trimesters.

f

Co-trimoxazole may cause neonatal haemolysis.